CA-125 as a biomarker for malignant transformation of endometriosis
作者： Jerome H. Check
DOI: 10.1016/J.FERTNSTERT.2009.02.036
关键词:
摘要:
fertstert.org
elsevier.com
sci-hub.se 参考文章(5)
Check Ml, Check Jh, Aikins J, Kiefer D, Ovarian cancer in a woman previously diagnosed with endometriosis and an extremely high serum CA-125 level. Clinical and Experimental Obstetrics & Gynecology. ,vol. 28, pp. 83- 85 ,(2001)
P A Canney, M Moore, P M Wilkinson, R D James, Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. British Journal of Cancer. ,vol. 50, pp. 765- 769 ,(1984) , 10.1038/BJC.1984.254
J.H. Check, M.D. Hornstein, Endometriosis causing very high early first trimester serum CA 125 levels. International Journal of Gynecology & Obstetrics. ,vol. 48, pp. 217- 218 ,(1995) , 10.1016/0020-7292(94)02253-U
Farr Nezhat, M. Shoma Datta, Veneta Hanson, Tanja Pejovic, Ceana Nezhat, Camran Nezhat, The relationship of endometriosis and ovarian malignancy: a review Fertility and Sterility. ,vol. 90, pp. 1559- 1570 ,(2008) , 10.1016/J.FERTNSTERT.2008.08.007
J. H. Check, T. E. Coates, K. Nowroozi, Extreme elevation of serum CA-125 in two women with severe endometriosis: case report. Gynecological Endocrinology. ,vol. 5, pp. 217- 220 ,(1991) , 10.3109/09513599109028444